Bath & Body Works (NYSE:BBWI) Earns “Outperform” Rating from Telsey Advisory Group

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reiterated by equities researchers at Telsey Advisory Group in a report issued on Thursday,Benzinga reports. They presently have a $43.00 price objective on the stock. Telsey Advisory Group’s target price points to a potential upside of 7.11% from the company’s previous close.

Several other equities research analysts also recently commented on the stock. Piper Sandler upped their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $42.00 to $48.00 in a research report on Friday, January 10th. JPMorgan Chase & Co. upgraded shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $41.00 to $47.00 in a report on Tuesday. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average price target of $43.63.

Bath & Body Works Stock Up 0.4 %

Bath & Body Works stock opened at $40.15 on Thursday. The stock has a market capitalization of $8.70 billion, a price-to-earnings ratio of 9.79, a P/E/G ratio of 0.96 and a beta of 1.83. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a 50-day simple moving average of $37.64 and a 200 day simple moving average of $33.76.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.48 earnings per share. As a group, sell-side analysts anticipate that Bath & Body Works will post 3.26 EPS for the current year.

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors have recently modified their holdings of BBWI. Wellington Management Group LLP bought a new stake in shares of Bath & Body Works during the third quarter worth about $8,129,000. Forest Avenue Capital Management LP grew its stake in shares of Bath & Body Works by 19.1% in the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company’s stock valued at $46,851,000 after buying an additional 235,173 shares during the period. Anthracite Investment Company Inc. bought a new stake in Bath & Body Works in the 3rd quarter valued at about $2,921,000. Principal Financial Group Inc. lifted its holdings in shares of Bath & Body Works by 328.7% in the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company’s stock worth $34,153,000 after purchasing an additional 820,379 shares in the last quarter. Finally, iA Global Asset Management Inc. raised its holdings in Bath & Body Works by 1,078.2% during the third quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company’s stock worth $1,575,000 after buying an additional 45,144 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.